US EditionPublished • loading... • Updated
Biotech Oragen Therapeutics Wants to Impose Oral Rna Against Large Laboratories
Summary by latribune.fr
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
In Besançon, the biotech Oragen Therapeutics develops an unprecedented technology of oral therapeutic RNA. A scientific and industrial bet that the SATT Sayens, the economic agency of Dijon, has decided to support by entering its capital.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
